United States · Platforms & data · MarketBeat

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Published by MarketBeat · United States 1 h ago

Insmed, Inc. (NASDAQ:INSM - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-five analysts that are presently covering the company,…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

MarketWatch

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Share

Also worth reading

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.